Acute renal failure due to mesangial proliferative glomerulonephritis in a pregnant woman with primary Sjögren's syndrome. 2006

Fatma Ulku Adam, and Dilek Torun, and Filiz Bolat, and Aysegul Zumrutdal, and Siren Sezer, and Fatma Nurhan Ozdemir
Department of Nephrology, Baskent University Faculty of Medicine, Adana Teaching and Medical Research Center, Dadaloglu Mah 39/6 PK, 01250 Adana, Yuregir, Turkey. ulkuadam@yahoo.com

The most common form of renal involvement in Sjögren's syndrome (SS) is tubulointerstitial nephritis. Renal dysfunction is usually mild and subclinical. Glomerulonephritis (GMN) is rare in patients with SS. We report a 28-year-old multigravida patient with primary Sjögren's syndrome (pSS) and associated manifestations, who presented with acute renal failure in the 20th week of her fifth pregnancy. The complaints and clinical findings, positive Schirmer's test, findings of dry eye on ophthalmologic examination, and the salivary gland biopsy were compatible with SS. The patient exhibited no other clinical or laboratory findings indicative of other collagenous disease and/or rheumatoid arthritis. She refused renal biopsy, hesitating for fear of fetal loss; thus, based on the clinical and laboratory findings indicating rapidly progressive GMN and vasculitis, prednisolone, plasmapheresis, and one dose of cyclophosphamide were administered during the pregnancy. Hemodialysis five times weekly was performed. At the 28th week of gestation, she underwent a cesarean section due to early rupture of membranes and fetal distress. A healthy male boy was delivered. The renal biopsy performed 2 weeks after labor revealed mesangial proliferative glomerulonephritis. After the fourth cyclophosphamide treatment, her urinary output increased and she was discharged from the hemodialysis program. She remains in follow-up at our outpatient clinic free of hemodialysis for 4 months. This is the first report of mesangial proliferative GMN requiring dialysis in a pregnant pSS patient that has featured good maternal and fetal outcomes.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011248 Pregnancy Complications Conditions or pathological processes associated with pregnancy. They can occur during or after pregnancy, and range from minor discomforts to serious diseases that require medical interventions. They include diseases in pregnant females, and pregnancies in females with diseases. Adverse Birth Outcomes,Complications, Pregnancy,Adverse Birth Outcome,Birth Outcome, Adverse,Complication, Pregnancy,Outcome, Adverse Birth,Pregnancy Complication
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012859 Sjogren's Syndrome Chronic inflammatory and autoimmune disease in which the salivary and lacrimal glands undergo progressive destruction by lymphocytes and plasma cells resulting in decreased production of saliva and tears. The primary form, often called sicca syndrome, involves both KERATOCONJUNCTIVITIS SICCA and XEROSTOMIA. The secondary form includes, in addition, the presence of a connective tissue disease, usually rheumatoid arthritis. Sicca Syndrome,Sjogren Syndrome,Sjogrens Syndrome,Syndrome, Sicca,Syndrome, Sjogren's

Related Publications

Fatma Ulku Adam, and Dilek Torun, and Filiz Bolat, and Aysegul Zumrutdal, and Siren Sezer, and Fatma Nurhan Ozdemir
December 1984, Clinical nephrology,
Fatma Ulku Adam, and Dilek Torun, and Filiz Bolat, and Aysegul Zumrutdal, and Siren Sezer, and Fatma Nurhan Ozdemir
March 2010, Pediatric nephrology (Berlin, Germany),
Fatma Ulku Adam, and Dilek Torun, and Filiz Bolat, and Aysegul Zumrutdal, and Siren Sezer, and Fatma Nurhan Ozdemir
January 2000, Renal failure,
Fatma Ulku Adam, and Dilek Torun, and Filiz Bolat, and Aysegul Zumrutdal, and Siren Sezer, and Fatma Nurhan Ozdemir
June 2006, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Fatma Ulku Adam, and Dilek Torun, and Filiz Bolat, and Aysegul Zumrutdal, and Siren Sezer, and Fatma Nurhan Ozdemir
December 1989, British journal of rheumatology,
Fatma Ulku Adam, and Dilek Torun, and Filiz Bolat, and Aysegul Zumrutdal, and Siren Sezer, and Fatma Nurhan Ozdemir
November 2000, Nephron,
Fatma Ulku Adam, and Dilek Torun, and Filiz Bolat, and Aysegul Zumrutdal, and Siren Sezer, and Fatma Nurhan Ozdemir
August 1989, Annals of the rheumatic diseases,
Fatma Ulku Adam, and Dilek Torun, and Filiz Bolat, and Aysegul Zumrutdal, and Siren Sezer, and Fatma Nurhan Ozdemir
July 1991, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Fatma Ulku Adam, and Dilek Torun, and Filiz Bolat, and Aysegul Zumrutdal, and Siren Sezer, and Fatma Nurhan Ozdemir
January 1986, American journal of nephrology,
Fatma Ulku Adam, and Dilek Torun, and Filiz Bolat, and Aysegul Zumrutdal, and Siren Sezer, and Fatma Nurhan Ozdemir
December 1998, Journal of Korean medical science,
Copied contents to your clipboard!